Increased Plasma Glycated Low-Density Lipoprotein Concentrations in Diabetes: A Marker of Atherogenic Risk
- 1 June 2004
- journal article
- research article
- Published by Mary Ann Liebert Inc in Diabetes Technology & Therapeutics
- Vol. 6 (3), 348-356
- https://doi.org/10.1089/152091504774198043
Abstract
Nonenzymatic glycation of apolipoprotein B in the low-density lipoprotein (LDL) complex has been considered a proatherogenic modification contributory to the increased susceptibility of patients with diabetes to atherosclerosis. We postulated that glycated LDL concentrations might be associated with other markers of cardiovascular disease. To explore this hypothesis, we measured glycated LDL concentrations by a monospecific immunoassay in 50 patients with type 1 and 100 patients with type 2 diabetes and examined relationships with the amount of albumin excretion and the serum cholesterol and triglyercide concentrations. Plasma glycated LDL showed a significant positive correlation (r = 0.325; P < 0.001) with urinary albumin excretion that was higher in type 1 (r = 0.463) than in type 2 (r = 0.245) patients. The mean glycated LDL concentration progressively increased with increasing albumin excretion when patients were subcategorized into groups of normoalbuminuria, low (≤100 μg/mg of creatinine), and high (101-300 μg/mg) microalbuminuria, and proteinuria. Glycated LDL also correlated positively and significantly with cholesterol (r = 0.578) and triglyceride (r = 0.350) concentrations. The significant correlations in this cross-sectional analysis between glycated LDL and urinary albumin excretion, an index of cardiovascular mortality, and cholesterol and triglyceride concentrations, traditional markers of risk for cardiovascular disease, support the hypothesis that an elevated level of glycated LDL represents an atherogenic risk factor in patients with diabetes.Keywords
This publication has 45 references indexed in Scilit:
- A Prospective Population-Based Study of Microalbuminuria as a Predictor of Mortality in NIDDMDiabetes Care, 1993
- Albuminuria and associated medical risk factors: A cross-sectional study in 451 type II (noninsulin-dependent) diabetic patients. Part 2Journal of Diabetic Complications, 1991
- Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetesBiochemical and Biophysical Research Communications, 1990
- Book ReviewAmbulatory Pediatric CareNew England Journal of Medicine, 1989
- Serum Lipids and Lipoproteins in Insulin‐dependent Diabetic Patients with Persistent MicroalbuminuriaDiabetic Medicine, 1989
- Microalbuminuria and its associated risk factors in a representative sample of Italian Type II diabeticsJournal of Diabetic Complications, 1988
- Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset DiabetesNew England Journal of Medicine, 1984
- Glycosylation of LDL decreases its ability to interact with high-affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivoBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982
- Glycosylation of human LDL and its metabolism in human skin fibroblastsBiochemical and Biophysical Research Communications, 1982
- Nonenzymatic glycosylation of low density lipoproteins in vitro. Effects on cell-interactive propertiesDiabetes, 1981